HCV reinfection rates in HIV-positive gay men
1 April 2011. Related: Conference reports.
Conference reports
1st International Workshop on HIV and Women, 10-11 January 2011, Washington
1 February 2011. Related: Conference reports.
Lopinavir/ritonavir: women versus men
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Quality of life in the GRACE study
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
Antiretroviral pharmacokinetics in women with undetectable viral load
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health.
No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Lipodystrophy and metabolic complications.
The impact of antiretroviral treatment on fertility intentions in South Africa
1 February 2011. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
41st Union World Conference on Lung Health, 11-15 November 2010, Berlin
1 February 2011. Related: Conference reports, TB coinfection.
Faster conversion rates with TMC-207 versus placebo plus OBT for the treatment of MDR-TB
1 February 2011. Related: Conference reports, TB coinfection.
Xpert MTB-RIF validation study from Tanzania
1 February 2011. Related: Conference reports, TB coinfection.
GeneXpert demonstrates good sensitivity and specificity but at high cost
1 February 2011. Related: Conference reports, TB coinfection.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 February 2011. Related: Conference reports.
Intestinal microflora and low grade metabolic inflammation
1 February 2011. Related: Conference reports, Lipodystrophy and metabolic complications.
Complex connections between bone and fat metabolism
1 February 2011. Related: Conference reports, PK and drug interactions, Lipodystrophy and metabolic complications.
10th International Congress on Drug Therapy in HIV Infection, 7-11 November 2010, Glasgow
1 December 2010. Related: Conference reports.
Virological findings from the SARA trial ofboosted protease inhibitor monotherapy
1 December 2010. Related: Conference reports, Antiretrovirals, Treatment access, Virology.
Nevirapine exposure was not associated with hypersensitivity in patients from Malawi
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Estimating the number of people in a country or region with HIV who are undiagnosed and in need of ART
1 December 2010. Related: Conference reports, Antiretrovirals.
Highpreterm delivery rates associated with initiation of HAART during pregnancy at a London clinic
1 December 2010. Related: Conference reports, Pregnancy.
Minority M184V variants detected in women after receiving 3TC/FTC and LPV/r-containing regimens in pregnancy
1 December 2010. Related: Conference reports, Pregnancy, Drug resistance.
The Antiretroviral Pregnancy Registry reports no increased rate of birth defects with atazanavir exposure
1 December 2010. Related: Conference reports, Pregnancy.
Pharmacokinetics of lopinavir/ritonavir incombination with rifampicin based TB treatment in children
1 December 2010. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Efavirenz versus nevirapine based first linetreatment in a South African cohort
1 December 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
GSK572: 24-week results in treatment-naive and raltegravir-experienced patients
1 December 2010. Related: Conference reports, Antiretrovirals.
Consensus guidelines recommend routine use of genotypic tropism testing: new focus on maraviroc as a switching option (2010)
1 December 2010. Related: Conference reports, Antiretrovirals, Guidelines.
UK studies on bone health: increasedfracture rates reported in HIV-positive people
1 December 2010. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Muscle weakness or pain analysed as possible raltegravir side effect
1 December 2010. Related: Conference reports, Antiretrovirals, Side effects.
Adding maraviroc does not boost CD4s inrandomised trial
1 December 2010. Related: Conference reports, Antiretrovirals.
Switch to twice-daily unboosted atazanavir outdoes switch to once-daily dose
1 December 2010. Related: Conference reports, Antiretrovirals.
Small but higher rates of AIDS and non-AIDS complications with uncontrolled HIV despite CD4s over 350
1 December 2010. Related: Conference reports, Antiretrovirals.
12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, 4-6 November 2010, London
1 December 2010. Related: Conference reports, Lipodystrophy and metabolic complications.
Bio-Alcamid associated with unacceptable risk of complications: no longer recommended as a treatment for facial lipoatrophy
1 December 2010. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
First International Workshop on HIV and Ageing, 4-5 October 2010, Baltimore
1 December 2010. Related: Conference reports.
T-cell senescence linked to KS in peoplewith good HIV control
1 December 2010. Related: Conference reports, Cancer and HIV, Basic science and immunology.
Higher risk of potential drug-drug interactions in HIV patients over 60
1 December 2010. Related: Conference reports, PK and drug interactions.
Age raises fracture risk more in HIV-positive people
1 December 2010. Related: Conference reports, Lipodystrophy and metabolic complications.
50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 12-15 September 2010, Boston
1 October 2010. Related: Conference reports.
Raltegravir pharmacokinetics inpregnancy
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Low birth weight associated with HAART in pregnancy in Zambia
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Bilirubin levels in infants following in utero atazanavir exposure compared to exposure to other antiretrovirals
1 October 2010. Related: Conference reports, Antiretrovirals, Pregnancy.
Novel mutations and shifting susceptibility to darunavir and tipranavir
1 October 2010. Related: Conference reports, Antiretrovirals, Drug resistance.
Four-drug single-pill antiretroviral equivalent to Atripla at 48 weeks
1 October 2010. Related: Conference reports, Antiretrovirals.
High rates of bone loss and progression with HIV in longitudinal study
1 October 2010. Related: Conference reports, Antiretrovirals, Side effects.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
1 October 2010. Related: Conference reports.
Spray-dried nanoparticle formulation of efavirenz
1 October 2010. Related: Conference reports, Antiretrovirals.
Switching boosted-PIs to raltegravir
1 October 2010. Related: Conference reports, Antiretrovirals, Treatment strategies.
Scaling up: what to do first?
1 October 2010. Related: Conference reports, Treatment strategies, Guidelines.
A new point of care CD4 test
1 October 2010. Related: Conference reports, Basic science and immunology.
Early infant diagnosis
1 October 2010. Related: Conference reports, Antiretrovirals, Paediatric care, Diagnostics.
Efavirenz-based regimens among womenof reproductive age receiving ART in Johannesburg
1 October 2010. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Male circumcision retains effectiveness at reducing risk of HIV infection: 54 month results
1 October 2010. Related: Conference reports, HIV prevention and transmission.
Towards a cure: HIV reservoirs and strategies to control them, 16–17 July 2010, Vienna
1 October 2010. Related: Conference reports, Cure-related research.
Rapporteur summaries
1 October 2010. Related: Conference reports, Basic science and immunology.
XVIII International AIDS Conference: 18-23 July 2010, Vienna
26 August 2010. Related: Conference reports.
Navigating the IAS Vienna conference online
26 August 2010. Related: Conference reports, On the web.
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Rilpivirine (TMC-278) vs efavirenz in treatment-naive patients: phase 3 results
26 August 2010. Related: Conference reports, Antiretrovirals.
Once-daily nevirapine extended release (XR) is non-inferior to current formulation
26 August 2010. Related: Conference reports, Antiretrovirals.
GSK572 (dolutegravir): second-generation integrase inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
TBR-652: early results for CCR5 inhibitor
26 August 2010. Related: Conference reports, Antiretrovirals.
Atazanavir/r plus maraviroc or tenofovir/FTC in treatment-naive patients
26 August 2010. Related: Conference reports, Antiretrovirals.
Unboosted twice-daily atazanavir plus raltegravir
26 August 2010. Related: Conference reports, Antiretrovirals.
CASCADE analysis of when to start treatment
26 August 2010. Related: Conference reports, Antiretrovirals.
Impact of antiretroviral PMTCT prophylaxis regimens on subsequent maternal disease progression in Kesho Bora
26 August 2010. Related: Conference reports, Antiretrovirals, Pregnancy.